Sort
50,496 grants matching “lung cancer”
Advancing Digital Pathology through Novel Machine Learning Methodologies
$591,896Saeed Hassanpour · Dartmouth College · R01 · FY2025 · LM
Advancing Digital Pathology through Novel Machine Learning Methodologies
$591,896Saeed Hassanpour · Dartmouth College · R01 · FY2024 · LM
Couple Communication Skills Training for Advanced Cancer
$591,875Laura S Porter · Duke University · R01 · FY2021 · CA
Targeting the Immune System in Mouse Models of Lung Adenocarcinoma
$591,863Katerina Abigail Politi · Yale University · R01 · FY2016 · CA
Biomarkers to Assess Selenium Chemoprevention for NSCLC
$591,792Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2011 · CA
Regulators of Cancer Immunotherapy Response
$591,752Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Protein Structure, Stability, and Amyloid Formation
$591,716Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Translating Autoantibodies Into Chimeric Antigen Receptor-T cell Therapy for Small Cell Lung Cancer
$591,527Kristin J Lastwika · Fred Hutchinson Cancer Center · U01 · FY2023 · CA
Project 2: Identifying Metabolic vulnerabilities and targets in cancers with mutations in hamartoma genes
$591,500David J. Kwiatkowski · Brigham And Women'S Hospital · P01 · FY2023 · CA
Raman Molecular Imaging for Early Detection of Colon Cancer
$591,483Olav Solgaard · Stanford University · R01 · FY2017 · CA
Eco-Evolutionary dynamics of NSCLC to immunotherapy: Response and Resistance
$591,459Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2022 · CA
A Phase 1 Trial of MLN0128 (sapanisertib) and CB-839 HCl (telaglenastat) in Advanced NSCLC Patients
$591,444Paul K Paik · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Promoting Physical Activity in Latinas via Interactive Web-based Technology
$591,349Bess Hya Marcus · University Of California, San Diego · R01 · FY2011 · CA
Development of a translational imaging tool as a predictive biomarker for anti-PD-1/PD-L1 immunotherapies
$591,330Michael John Evans · University Of California, San Francisco · R01 · FY2020 · EB
New Chemical Methods for Molecular Imaging to Impact Clinical Care
$591,266Tobias Ritter · Harvard University · R01 · FY2011 · EB
Chemoprevention of experimental tobacco tumorigenesis.
$591,145University Of Louisville · R01 · FY2004 · CA
A platform to functionally sort and analyze tumor cells within combinatorial metastatic micorenvironments
$591,141David Kevin Wood · University Of Minnesota · R01 · FY2021 · CA
Inflammation and cancer treatment
$591,012David Wink · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Mechanistic factors limiting utility of adenovirus vectors for treatment of neopla
$590,956Dmitry Shayakhmetov · Emory University · R01 · FY2024 · CA
Simulating Protein Structures, Complexes, And Dynamics
$590,933Peter J Steinbach · Center For Information Technology · ZIA · FY2015 · CT
Optical Nanoscale Analysis of Buccal Cells: Transforming Lung Cancer Screening
$590,916Vadim Backman · Northwestern University · R01 · FY2012 · CA
Small-Molecule Antagonists of Ral GTPases in Cancer
$590,913Samy Meroueh · Indiana University Indianapolis · R01 · FY2017 · CA
Postdoctoral training in tobacco control
$590,861Stanton Arnold Glantz · University Of California, San Francisco · R25 · FY2015 · CA
Leveraging canine spontaneous cancer to optimize the power of blood biopsy
$590,812Elinor Karlsson · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · CA
Alternative Fuel Use to Reduce Diesel Emissions Exposure and Toxicity in Mining
$590,809Jefferey L Burgess · University Of Arizona · R01 · FY2018 · OH